DEXCOM INC. DL-,001/ US2521311074 /
14/06/2024 09:19:56 | Chg. -2.04 | Volume | Bid20:59:40 | Ask20:59:40 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.92EUR | -1.89% | 8 Turnover: 847.36 |
-Bid Size: - | -Ask Size: - | 43.07 bill.EUR | - | - |
GlobeNewswire
08/04
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
31/01
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.